Evogene holds special shareholder meeting
EVGN•Evogene shareholders approved all three proposals at a special general meeting on November 10, 2026, including a cooperation agreement that took effect at the meeting’s close.
1. Proposals approved
The approved cooperation agreement is with L.I.A. Pure Capital and Invest-Pro Shukai Hon. The resulting seven-member board includes President and CEO Ofer Haviv.
